Can You Have Kava While Pregnant or Breastfeeding?

Kava should be avoided during both pregnancy and breastfeeding. No health authority with jurisdiction over maternal safety considers kava safe for use during these periods, and the limited evidence that does exist points toward real risks for the developing baby. The active compounds in kava cross biological barriers, interact with drug-metabolizing enzymes, and have been linked to at least one documented case of serious harm to a newborn. The lack of large-scale human studies does not mean the risk is theoretical; it means the substance has not been tested enough to establish any safe dose for pregnant or nursing women.

What Kava Does and Why That Matters for Pregnancy

Kava’s effects come from a group of compounds called kavalactones, which act on the central nervous system. These compounds produce the calming, mildly sedative feeling that makes kava popular for stress and anxiety relief. Despite centuries of traditional use in Pacific Island cultures, the exact way kavalactones affect the brain is still not well characterized. Researchers know they produce potent central nervous system effects in both clinical settings and animal models, but the specific pathways remain poorly understood.1PubMed. DARK Classics in Chemical Neuroscience: Kava

That gap in understanding is itself part of the problem for pregnant women. When a substance’s mechanism of action is not fully mapped, predicting what it will do to a developing fetus becomes much harder. The central nervous system is one of the first and most complex systems to develop in utero, and substances that cross into the brain are generally treated with extreme caution during pregnancy. Kavalactones are lipophilic, meaning they dissolve readily in fats, which is exactly the property that helps compounds cross the placenta.

Documented Harm to a Newborn

The strongest direct evidence of fetal harm from maternal kava use comes from a case report documenting a baby born with ichthyosiform dermopathy, a condition where the skin becomes dry, thickened, and scaly in a pattern resembling fish scales. The mother had consumed kava during pregnancy and herself developed a similar skin condition, which is a recognized side effect of heavy kava use sometimes called “kava dermopathy.” The case report concluded that maternal kava use during pregnancy may cause this acquired skin condition in the fetus.2PubMed Central. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy

A single case report does not prove that every woman who drinks kava during pregnancy will see this outcome. But it establishes something important: kavalactones or their metabolites do reach the fetus in quantities sufficient to cause visible, measurable effects. Kava dermopathy in adults is dose-dependent and usually reversible when kava use stops, but its implications for a developing baby, whose skin barrier and detoxification systems are immature, are more concerning. The fact that this condition appeared in the newborn essentially confirms placental transfer of kava’s active compounds.

Liver Toxicity Applies to Mother and Baby

Beyond skin effects, kava carries a well-documented risk of liver damage. This issue led several countries, including Germany and others in the European Union, to temporarily ban kava products in the early 2000s. The liver toxicity question is complicated because it appears to depend partly on how the kava is prepared. Comparing commercial extracts, which use organic solvents like acetone or ethanol, with traditional aqueous preparations reveals significant differences in the ratio of major kavalactones and in their ability to inhibit key liver enzymes. In laboratory comparisons, commercial preparations showed more potent inhibition of drug-metabolizing enzymes than the traditional water-based beverage.3PubMed. Composition and biological activity of traditional and commercial kava extracts

For a while, this led to a popular narrative that traditional kava was safe and only commercial supplements were dangerous. That distinction does not hold up as cleanly as people hoped. Research has shown that hepatotoxicity can also occur with traditional aqueous kava extracts of the kind consumed in the South Pacific, suggesting the toxicity is linked to the kava plant itself rather than exclusively to the solvents used in commercial extraction. The quality of the kava cultivar and which plant parts are used also play a role.4PubMed. Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures

During pregnancy, liver function matters even more than usual. Your liver is already working harder to process the increased blood volume and hormonal load that come with carrying a baby. Adding a substance with known hepatotoxic potential puts additional stress on an already-taxed system. And for the fetus, whose liver is still developing and cannot efficiently process toxins, even modest exposure to hepatotoxic compounds raises the stakes considerably.

Drug Interactions Are a Serious Concern

One of the more concrete dangers of kava during pregnancy involves its interactions with other medications. Several kavalactones are potent inhibitors of multiple enzymes in the cytochrome P450 system, which is the primary pathway your body uses to break down medications and other foreign compounds. Kava has been shown to inhibit CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A4, and CYP4A9/11, which means it has a high potential for causing drug interactions with a wide range of pharmaceuticals.5PubMed. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.)

In practical terms, this is dangerous because pregnant women frequently take medications that rely on these same enzymes for safe metabolism. Prenatal vitamins with iron, antinausea drugs, blood pressure medications for preeclampsia, antibiotics for Group B strep, and even common over-the-counter pain relievers all pass through the CYP450 system. If kava is slowing down those enzymes, the effective dose of those medications changes unpredictably. A drug that was prescribed at a safe level could accumulate to a harmful one, or a drug meant to protect you or your baby could lose effectiveness because its metabolic pathway is disrupted.

This interaction risk does not require heavy kava use. Even moderate consumption can affect enzyme activity, and the effects can linger after you stop drinking kava because the inhibition is not always immediately reversible. For anyone taking prescription medications during pregnancy, which is a large share of pregnant women, adding kava creates a layer of pharmacological unpredictability that no provider would consider acceptable.

Breastfeeding Carries Its Own Risks

The data on kava and breastfeeding is even thinner than the data on pregnancy, but the reasoning for avoidance is straightforward. Kavalactones are fat-soluble, and breast milk is rich in fats. Compounds that dissolve easily in lipids tend to concentrate in breast milk, sometimes at levels higher than those found in the mother’s bloodstream. A nursing infant’s liver and kidneys are still maturing and cannot detoxify substances as efficiently as an adult’s body can.

No studies have measured kavalactone concentrations in human breast milk, which means there is no established safe threshold. The absence of data is not reassurance; it is the opposite. When a substance is known to be centrally active, potentially hepatotoxic, and fat-soluble, the default assumption in lactation pharmacology is that it transfers into milk and poses a risk until proven otherwise. This is the same logic that leads to caution around alcohol, certain herbal supplements, and sedating medications during breastfeeding.

There is also a practical timing issue. Kava’s sedative effects could affect your alertness and reaction time during the period when you are responsible for the care of a newborn. Even if the transfer into milk were minimal, the impact on your own ability to respond safely to your baby’s needs at night is a separate reason for caution.

Why Some Pregnant and Postpartum Women Seek Kava Anyway

It is worth acknowledging why this question comes up at all. Anxiety and depression during pregnancy and the postpartum period are common, affecting a substantial percentage of women. The appeal of a “natural” remedy like kava is understandable, especially when conventional treatments feel unappealing or frightening. Research on postpartum mental health has documented that many women who are prescribed psychiatric medications during pregnancy or breastfeeding do not follow through with those prescriptions, sometimes out of fear and sometimes without telling their provider.6Wolters Kluwer / Ovid. Treating Postpartum Depression and Anxiety Naturally

This creates a gap. A woman who is struggling with anxiety but unwilling to take a prescribed SSRI might turn to kava because it feels safer, more controllable, or less medicalized. The problem is that “natural” does not mean “safe for pregnancy.” Kava is a pharmacologically active substance with real effects on brain chemistry, liver function, and enzyme systems. It is not a mild herbal tea; it is a potent psychoactive preparation that just happens to come from a plant. The distinction between “natural” and “pharmaceutical” is a marketing category, not a safety classification.

If you are dealing with anxiety or depression during pregnancy or while breastfeeding and want to avoid conventional medications, that is a conversation worth having openly with your healthcare provider. There are evidence-based non-pharmacological approaches, including certain forms of therapy and structured behavioral interventions, that have shown benefit for perinatal mood disorders. But substituting an unregulated herbal psychoactive for a regulated and studied medication is not the safer path, even though it can feel that way.

Supplement Quality Makes the Problem Worse

If the pharmacological risks of kava were not enough, the supplement market adds another layer of uncertainty. Kava dietary supplements are not regulated with the same rigor as pharmaceutical drugs. The composition of what you are actually consuming varies widely between products. Analysis of kava supplement products has found that while most contained negligible levels of pipermethystine, a compound found in kava leaves and stems that has been linked to liver toxicity, at least one product sold as a mixture of kava roots and leaves did contain detectable amounts.7ACS Symposium Series. Dietary Supplements

Traditionally, only the root of the kava plant is used to prepare the beverage. The above-ground parts of the plant, particularly the leaves and stems, contain different chemical profiles and are associated with greater toxicity. But in the supplement industry, where cost pressures and inconsistent sourcing are common, there is no guarantee that a capsule or extract marketed as “kava root” contains only root material. This matters for everyone who takes kava, but it matters especially for pregnant and breastfeeding women, who are exposing not just themselves but a developing or nursing infant to whatever contaminants or adulterants happen to be in the product.

There is no reliable way for a consumer to verify the purity or composition of a kava supplement at home. Third-party testing certifications exist for some products, but they are voluntary and do not specifically test for all the compounds relevant to kava safety. Even if you trust a particular brand, batch-to-batch variation is a reality in the supplement market.

Traditional Use in Pacific Island Cultures

Some people argue that kava must be safe because Pacific Islander communities have consumed it for centuries. This argument has some merit when applied to healthy, non-pregnant adults drinking traditionally prepared kava in a ceremonial or social context. The traditional preparation involves grinding the root and mixing it with water, which produces a different chemical profile than commercial solvent-based extractions. However, research comparing the two found that while commercial preparations were more potent enzyme inhibitors, the traditional aqueous form was not free of hepatotoxic potential.3PubMed. Composition and biological activity of traditional and commercial kava extracts

It is also worth noting that traditional use patterns in Pacific Island cultures typically excluded pregnant women or limited their consumption. The argument from tradition, when examined honestly, often supports the case for caution during pregnancy rather than undermining it. Many traditional societies that use pharmacologically active plants have their own versions of pregnancy restrictions around those plants, developed through generations of observation even without formal clinical trials.

The broader point is that “traditional use” tells you something about a substance’s safety profile in the population that traditionally used it, under the conditions they traditionally used it, at the doses they traditionally consumed. It does not tell you that the substance is safe for every subpopulation, at every dose, in every preparation, under every circumstance. Pregnancy is precisely the kind of circumstance where the general safety profile of a substance does not automatically extend.

What About Kava Tea or Low-Dose Products

You might wonder whether a single cup of kava tea, which typically contains much less kavalactone than a concentrated supplement, is meaningfully different from taking capsules or tinctures. In theory, the dose matters. Kava dermopathy, liver damage, and heavy sedation are associated with regular or high-dose use. A single weak cup of kava tea delivers far less kavalactone than a standardized supplement capsule.

The problem is that there is no established safe dose of kava during pregnancy or breastfeeding. Without that threshold, there is no way to say with confidence that any particular serving falls below it. The case report of neonatal dermopathy involved a mother who used kava during pregnancy, but the exact dose and frequency were not standardized in a way that allows you to extrapolate a “safe” amount from it.2PubMed Central. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy And given kava’s ability to inhibit drug-metabolizing enzymes, even a low dose could interfere with medications you are taking during pregnancy.5PubMed. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.)

The honest answer is that nobody has done the work needed to identify a safe dose for this population, and given the ethical impossibility of running randomized trials on pregnant women with a substance already suspected of causing harm, nobody is likely to do that work anytime soon. In the meantime, the prudent course is avoidance. If you consumed kava before realizing you were pregnant, a single exposure is unlikely to cause the kind of cumulative damage seen with regular use, but it is still worth mentioning to your provider so they can factor it into your care.